Table 1.
NTRK1 mutation | TRKA protein | Full glycosylation | Membrane expression | Autophos‐phorylation | Y496 phos‐phorylation | PLCγ activation | Neurite outgrowth |
---|---|---|---|---|---|---|---|
c.1550G > A | p.G517E | No effect | No effect | No effect | No effect | Abolished | Reduced |
c.1565G > A | p.G522E | No effect | No effect | Abolished | Abolished | Abolished | ‐ |
c.1970T > C | p.L657P | Reduced | Reduced | Abolished | Abolished | Abolished | Abolished |
c.2096T > C | p.I699T | Reduced | Reduced | Abolished | Abolished | Abolished | ‐ |
c.2254T > A | p.C752S | No effect | No effect | No effect | No effect | No effect | No effect |
c.2288G > C | p.C763S | Reduced | Reduced | Reduced | Reduced | Reduced | Reduced |
c.2311C>T | p.R771C | Reduced | Reduced | Abolished | Abolished | Abolished | ‐ |
GFP tagged constructs of wild‐type TRKA and each mutation were used to asses pathogenicity (RefSeq ID NM_002529.3, NP_002520).